Ascletis Pharma Inc. ( ASCLF) - Stock Earnings
ASCLF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 24, 2026, midnight | — / — | — | — / — | — |
ASCLF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -170.6 million USD | 1.3 million USD |
| 2025Q1 | -44.0 million USD | 540500 USD |
| 2025Q2 | -88.0 million USD | 1.1 million USD |
ASCLF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -314.8 million USD | 54.1 million USD |
| 2023 | -144.7 million USD | 56.6 million USD |
| 2024 | -300.9 million USD | 1.3 million USD |
| 2026 Est. | — | — |
ASCLF
Price: $1.30
52 week price:
Earnings Per Share: -0.05 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.1 billion